Home / Stocks / AURX

AURX insider trading

Nuo Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$303k
Buys · last 90 days
1 · $10k
Most recent buy
2026-08-31

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-31JORDEN DAVID EMERSON
CEO/CFO
Bought8,773$1.09$10k
2025-08-01SHEEDY CHARLES E
10% owner
Bought133,333$1.50$200k
2024-09-19SHEEDY CHARLES E
10% owner
Bought125,000$0.75$94k

Most active insider buyers

InsiderRoleBuysTotal bought
SHEEDY CHARLES E10% owner2$294k
JORDEN DAVID EMERSONCEO/CFO1$10k

See AURX on the chart

Every insider buy and sell for AURX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.